Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1261 AL 1275

Ethnobotanical significance of medicinal plants: Beta-amyloid and tau aggregation inhibitors against Alzheimer's disease

Ganapathy AA, Haripriya VM, Acharya N, Somappa SB, Kumaran A.

J Biochem Mol Toxicol. 2023 Jun;37(6):e23339. doi: 10.1002/jbt.23339. Epub 2023 Apr 3.

Thiadiazole - A promising structure in design and development of anti-Alzheimer agents

Hatami M, Basri Z, Sakhvidi BK, Mortazavi M.

Int Immunopharmacol. 2023 May;118:110027. doi: 10.1016/j.intimp.2023.110027. Epub 2023 Apr 1.

Repurposing drugs against Alzheimer's disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?

Leßmann V, Kartalou GI, Endres T, Pawlitzki M, Gottmann K.

J Neural Transm (Vienna). 2023 Aug;130(8):1003-1012. doi: 10.1007/s00702-023-02618-5. Epub 2023 Apr 4.

Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer's disease

Young-Pearse TL, Lee H, Hsieh YC, Chou V, Selkoe DJ.

Trends Neurosci. 2023 Jun;46(6):426-444. doi: 10.1016/j.tins.2023.03.005. Epub 2023 Apr 3.

Geroprotective interventions in the 3xTg mouse model of Alzheimer's disease

Sonsalla MM, Lamming DW.

Geroscience. 2023 Jun;45(3):1343-1381. doi: 10.1007/s11357-023-00782-w. Epub 2023 Apr 6.

Docosahexaenoic acid inhibits ischemic stroke to reduce vascular dementia and Alzheimer's disease

Yamagata K.

Prostaglandins Other Lipid Mediat. 2023 Aug;167:106733. doi: 10.1016/j.prostaglandins.2023.106733. Epub 2023 Apr 5.

Piperidine Nucleus as a Promising Scaffold for Alzheimer's Disease: Current Landscape and Future Perspective

Grover P, Rohilla S, Bhardwaj M, Mehta L, Malhotra A.

Curr Top Med Chem. 2023;23(13):1221-1259. doi: 10.2174/1568026623666230406084315.

Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer's Disease: Mechanisms and Clinical Implications

Xu Y, Zheng F, Zhong Q, Zhu Y.

J Alzheimers Dis. 2023;92(4):1173-1198. doi: 10.3233/JAD-230002.

Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial

Berry DA, Dhadda S, Kanekiyo M, Li D, Swanson CJ, Irizarry M, Kramer LD, Berry SM.

JAMA Netw Open. 2023 Apr 3;6(4):e237230. doi: 10.1001/jamanetworkopen.2023.7230.

The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathies

Lozupone M, Dibello V, Sardone R, Castellana F, Zupo R, Lampignano L, Bortone I, Stallone R, Altamura M, Bellomo A, Daniele A, Solfrizzi V, Panza F.

Expert Opin Drug Discov. 2023 May;18(5):515-526. doi: 10.1080/17460441.2023.2200245. Epub 2023 Apr 11.

The future of alzheimer disease immunotherapies in Saudi Arabia: Consensus statement of the Saudi Chapter of Cognitive and Behavioral Neurology

Tayeb HO, Khallaf RA, Muayqil TA, Alkeridy WA, Alibrahim FS, Alfaify OA, Qadi N, Tarazi FI.

Neurosciences (Riyadh). 2023 Apr;28(2):77-84. doi: 10.17712/nsj.2023.2.20220133.

Vitamin D and Its Analogues: From Differences in Molecular Mechanisms to Potential Benefits of Adapted Use in the Treatment of Alzheimer's Disease

Thiel A, Hermanns C, Lauer AA, Reichrath J, Erhardt T, Hartmann T, Grimm MOW, Grimm HS.

Nutrients. 2023 Mar 30;15(7):1684. doi: 10.3390/nu15071684.

Structural polymorphism and cytotoxicity of brain-derived β-amyloid extracts

Al Adem K, Lee S.

Protein Sci. 2023 May;32(5):e4639. doi: 10.1002/pro.4639.

Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer's disease?

Petrovskaya A, Tverskoi A, Medvedeva A, Nazarova M.

Commun Biol. 2023 Apr 14;6(1):416. doi: 10.1038/s42003-023-04717-1.

Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)

Lanctôt KL, Chen C, Mah E, Kiss A, Li A, Shade D, Scherer RW, Vieira D, Coulibaly H, Rosenberg PB, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer J, Herrmann N.

Int Psychogeriatr. 2023 Nov;35(11):664-672. doi: 10.1017/S1041610223000327. Epub 2023 Apr 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias